The urgent demand for transplanted organs has motivated the development of regenerative medicine to biomimetically reconstruct the structure and function of natural tissues or organs. The prerequisites for constructing multicellular organs include specific cell sources, suitable scaffolding material, and interconnective biofunctional interfaces. As some of the most complex systems in nature, human organs, tissues, and cellular units have unique “bio-matrix” physicochemical interfaces. Human tissues support a large number of cells with distinct biofunctional interfaces for compartmentalization related to metabolism, material exchange, and physical barriers. These naturally shaped biofunctional interfaces support critical metabolic functions that drive adaptive human behavior. In contrast, mutations and disorders during organogenesis can disrupt these interfaces as a consequence of disease and trauma. To replicate the appropriate structure and physiological function of tissues and organs, the biomaterials used in these approaches should have properties that mimic those of natural biofunctional interfaces. In this review, the focus is on the biomimetic design of functional interfaces and hierarchical structures for four regenerative organs, liver, kidney, lung, heart, and the immune system. Research on these organs provides understanding of cell–matrix interactions for hierarchically bioinspired material engineering, and guidance for the design of bioartificial organs. Finally, we provide perspectives on future challenges in biofunctional interface designs and discuss the obstacles that remain toward the generation of functional bioartificial organs.
Impact statement
Naturally shaped biofunctional interfaces support critical metabolic functions that drive adaptive human behavior. To rebuild the appropriate structure and physiological function of tissues and organs, the biomaterials should have properties that mimic those of natural biofunctional interfaces. This review highlights the biomimetic design of biofunctional interfaces through introducing the biofunctional interfaces from hierarchical structure of major material exchanging organs and summarizing current interface engineering that can achieve the biomimetic design of biofunctional interfaces of natural organs.
Get full access to this article
View all access options for this article.
References
1.
XuR., WangK., ChenG., and YanW.Condensed-matter chemistry: from materials to living organisms. Natl Sci Rev, 6, 191, 2019.
2.
SakimotoK.K., KornienkoN., Cestellos-BlancoS., LimJ., LiuC., and YangP.Physical biology of the materials-microorganism interface. J Am Chem Soc, 140, 1978, 2018.
3.
SarangiB.R., GuptaM., DossB.L., et al.Coordination between Intra- and extracellular forces regulates focal adhesion dynamics. Nano Lett, 17, 399, 2017.
4.
FongE.L., HarringtonD.A., Farach-CarsonM.C., and YuH.Heralding a new paradigm in 3D tumor modeling. Biomaterials, 108, 197, 2016.
5.
HuS., DasbiswasK., GuoZ., et al.Long-range self-organization of cytoskeletal myosin Ii filament stacks. Nat Cell Biol, 19, 133, 2017.
6.
BertocchiC., WangY., RavasioA., et al.Nanoscale architecture of cadherin-based cell adhesions. Nat Cell Biol, 19, 28, 2017.
7.
CaiazzoM., OkawaY., RangaA., PiersigilliA., TabataY., and LutolfM.P.Defined three-dimensional microenvironments boost induction of pluripotency. Nat Mater, 15, 344, 2016.
8.
GrafahrendD., HeffelsK.H., BeerM.V., et al.Degradable polyester scaffolds with controlled surface chemistry combining minimal protein adsorption with specific bioactivation. Nat Mater, 10, 67, 2011.
9.
Bartolak-SukiE., ImsirovicJ., ParameswaranH., et al.Fluctuation-driven mechanotransduction regulates mitochondrial-network structure and function. Nat Mater, 14, 1049, 2015.
10.
PurcellB.P., LobbD., CharatiM.B., et al.Injectable and bioresponsive hydrogels for on-demand matrix metalloproteinase inhibition. Nat Mater, 13, 653, 2014.
11.
CelizA.D., SmithJ.G., LangerR., et al.Materials for stem cell factories of the future. Nat Mater, 13, 570, 2014.
12.
YeK., WangX., CaoL., et al.Matrix stiffness and nanoscale spatial organization of cell-adhesive ligands direct stem cell fate. Nano Lett, 15, 4720, 2015.
13.
YangC., TibbittM.W., BastaL., and AnsethK.S.Mechanical memory and dosing influence stem cell fate. Nat Mater, 13, 645, 2014.
14.
BonakdarN., GerumR., KuhnM., et al.Mechanical plasticity of cells. Nat Mater, 15, 1090, 2016.
15.
ChaeS.K., KangE., KhademhosseiniA., and LeeS.H.Micro/nanometer-scale fiber with highly ordered structures by mimicking the spinning process of silkworm. Adv Mater, 25, 3071, 2013.
16.
HanW.M., HeoS.J., DriscollT.P., et al.Microstructural heterogeneity directs micromechanics and mechanobiology in native and engineered fibrocartilage. Nat Mater, 15, 477, 2016.
17.
McMurrayR.J., GadegaardN., TsimbouriP.M., et al.Nanoscale surfaces for the long-term maintenance of mesenchymal stem cell phenotype and multipotency. Nat Mater, 10, 637, 2011.
18.
CosgroveB.D., MuiK.L., DriscollT.P., et al.N-Cadherin adhesive interactions modulate matrix mechanosensing and fate commitment of mesenchymal stem cells. Nat Mater, 15, 1297, 2016.
19.
ParkJ., KimD.H., KimH.N., et al.Directed migration of cancer cells guided by the graded texture of the underlying matrix. Nat Mater, 15, 792, 2016.
20.
WangS., WanY., and LiuY.Effects of nanopillar array diameter and spacing on cancer cell capture and cell behaviors. Nanoscale, 6, 12482, 2014.
MayorR., and Etienne-MannevilleS.The front and rear of collective cell migration. Nat Rev Mol Cell Biol, 17, 97, 2016.
23.
HuJ., GondarenkoA.A., DangA.P., et al.High-throughput mechanobiology screening platform using micro- and nanotopography. Nano Lett, 16, 2198, 2016.
24.
CasaresL., VincentR., ZalvideaD., et al.Hydraulic fracture during epithelial stretching. Nat Mater, 14, 343, 2015.
25.
LeeJ., AbdeenA.A., WycisloK.L., FanT.M., and KilianK.A.Interfacial geometry dictates cancer cell tumorigenicity. Nat Mater, 15, 856, 2016.
26.
ReffayM., ParriniM.C., Cochet-EscartinO., et al.Interplay of rhoa and mechanical forces in collective cell migration driven by leader cells. Nat Cell Biol, 16, 217, 2014.
27.
MiyauchiA., KuwabaraK., HasegawaM., and OginoM.Large-area nanoimprint and application to cell cultivation. Appl Phys A, 122, 2016.
28.
GrashoffC., HoffmanB.D., BrennerM.D., et al.Measuring mechanical tension across vinculin reveals regulation of focal adhesion dynamics. Nature, 466, 263, 2010.
29.
FuJ., WangY.K., YangM.T., et al.Mechanical regulation of cell function with geometrically modulated elastomeric substrates. Nat Methods, 7, 733, 2010.
30.
MeiF., FancyS.P., ShenY.A., et al.Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis. Nat Med, 20, 954, 2014.
31.
ChungT.W., LiuD.Z., WangS.Y., and WangS.S.Enhancement of the growth of human endothelial cells by surface roughness at nanometer scale. Biomaterials, 24, 4655, 2003.
32.
De BartoloL., RendeM., MorelliS., et al.Influence of membrane surface properties on the growth of neuronal cells isolated from hippocampus. J Membr Sci, 325, 139, 2008.
33.
HanawaT.Titanium-tissue interface reaction and its control with surface treatment. Front Bioeng Biotechnol, 7, 170, 2019.
34.
MertgenA.S., TrossmannV.T., GuexA.G., Maniura-WeberK., ScheibelT., and RottmarM.Multifunctional biomaterials: combining material modification strategies for engineering of cell-contacting surfaces. ACS Appl Mater Interfaces, 12, 21342, 2020.
RowlandsA.S., GeorgeP.A., and Cooper-WhiteJ.J.Directing osteogenic and myogenic differentiation of MSCs: interplay of stiffness and adhesive ligand presentation. Am J Physiol Cell Physiol, 295, C1037, 2008.
PeytonS.R., RaubC.B., KeschrumrusV.P., and PutnamA.J.The use of poly(ethylene glycol) hydrogels to investigate the impact of ECM chemistry and mechanics on smooth muscle cells. Biomaterials, 27, 4881, 2006.
39.
HaleN.A., YangY., and RajagopalanP.Cell migration at the interface of a dual chemical-mechanical gradient. ACS Appl Mater Interfaces, 2, 2317, 2010.
40.
ZhangW., WangR., SunZ., et al.Catechol-functionalized hydrogels: biomimetic design, adhesion mechanism, and biomedical applications. Chem Soc Rev, 49, 433, 2020.
41.
BhatiaS.N., UnderhillG.H., ZaretK.S., and FoxI.J.Cell and tissue engineering for liver disease. Sci Transl Med, 6, 245sr2, 2014.
42.
ZhangJ., ZhaoX., LiangL., LiJ., DemirciU., and WangS.A decade of progress in liver regenerative medicine. Biomaterials, 157, 161, 2018.
43.
SawT.B., XiW., LadouxB., and LimC.T.Biological tissues as active nematic liquid crystals. Adv Mater, 30, 2018.
44.
Morales-NavarreteH., NonakaH., ScholichA., et al.Liquid-crystal organization of liver tissue. Elife, 8, 2019.
45.
MarinoM.Constitutive Modeling of Soft Tissues, Encyclopedia of Biomedical Engineering. New York, NY: Elsevier, 2019, pp. 81–110.
46.
GonzalesR.C., and WintzP.Image Model-Image Transforms. Digital Image Processing Chapter 2 and 3. London: Pearson, 1977.
47.
MazzaG., Al-AkkadW., RomboutsK., and PinzaniM.Liver tissue engineering: from implantable tissue to whole organ engineering. Hepatol Commun, 2, 131, 2018.
48.
FengZ.Q., ChuX., HuangN.P., et al.The effect of nanofibrous galactosylated chitosan scaffolds on the formation of rat primary hepatocyte aggregates and the maintenance of liver function. Biomaterials, 30, 2753, 2009.
49.
WangL., ZhouY., DaiJ., et al.2-Thiophene ethylamine modified hyaluronic acid with its application on hepatocytes culture. Mater Sci Eng C Mater Biol Appl, 88, 157, 2018.
50.
AgarwalT., MaitiT.K., and GhoshS.K.Decellularized caprine liver-derived biomimetic and pro-angiogenic scaffolds for liver tissue engineering. Mater Sci Eng C Mater Biol Appl, 98, 939, 2019.
51.
WangX., CuiJ., ZhangB.Q., et al.Decellularized liver scaffolds effectively support the proliferation and differentiation of mouse fetal hepatic progenitors. J Biomed Mater Res A, 102, 1017, 2014.
52.
StarokozhkoV., HemmingsenM., LarsenL., et al.Differentiation of human-induced pluripotent stem cell under flow conditions to mature hepatocytes for liver tissue engineering. J Tissue Eng Regen Med, 12, 1273, 2018.
53.
WangX., and LiuC.Fibrin hydrogels for endothelialized liver tissue engineering with a predesigned vascular network. Polymers (Basel), 10, 1048, 2018.
54.
BishiD.K., MathapatiS., VenugopalJ.R., et al.A patient-inspired ex vivo liver tissue engineering approach with autologous mesenchymal stem cells and hepatogenic serum. Adv Healthc Mater, 5, 1058, 2016.
55.
YangH., SunL., PangY., et al.Three-dimensional bioprinted hepatorganoids prolong survival of mice with liver failure. Gut gutjnl, 2020. gutjnl-2019-319960. DOI: 10.1136/gutjnl-2019-319960
56.
An Update on Organoid Research. Nat Cell Biol, 20, 633, 2018.
57.
CampJ.G., SekineK., GerberT., et al.Multilineage communication regulates human liver bud development from pluripotency. Nature, 546, 533, 2017.
58.
SunL., WangY., CenJ., et al.Modelling liver cancer initiation with organoids derived from directly reprogrammed human hepatocytes. Nat Cell Biol, 21, 1015, 2019.
59.
Ortega-PrietoA.M., SkeltonJ.K., WaiS.N., et al.3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infection. Nat Commun, 9, 682, 2018.
60.
GrassiL., AlfonsiR., FrancescangeliF., et al.Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases. Cell Death Dis, 10, 201, 2019.
61.
KawaguchiM., YamamotoK., TakedaN., et al.Hepatocyte growth factor activator inhibitor-2 stabilizes Epcam and maintains epithelial organization in the mouse intestine. Commun Biol, 2, 11, 2019.
62.
KatsudaT., KawamataM., HagiwaraK., et al.Conversion of terminally committed hepatocytes to culturable bipotent progenitor cells with regenerative capacity. Cell Stem Cell, 20, 41, 2017.
63.
FuG.-B., HuangW.-J., ZengM., et al.Expansion and differentiation of human hepatocyte-derived liver progenitor-like cells and their use for the study of hepatotropic pathogens. Cell Res, 29, 8, 2018.
64.
HuchM., DorrellC., BojS.F., et al.In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration. Nature, 494, 247, 2013.
65.
ZhangK., ZhangL., LiuW., et al.In vitro expansion of primary human hepatocytes with efficient liver repopulation capacity. Cell Stem Cell, 23, 806, 2018.
66.
PengW.C., LoganC.Y., FishM., et al.Inflammatory cytokine Tnfα promotes the long-term expansion of primary hepatocytes in 3d culture. Cell, 175, 1607, 2018.
67.
HuchM., GehartH., van BoxtelR., HamerK., et al.Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell, 160, 299, 2015.
68.
HuH., GehartH., ArtegianiB., et al.Long-term expansion of functional mouse and human hepatocytes as 3d organoids. Cell, 175, 1591, 2018.
69.
ChenS., KhouryC., and ZiyadehF.N.Chapter 78 – Pathophysiology and pathogenesis of diabetic nephropathy. In: AlpernR.J., MoeO.W., CaplanM. eds. Seldin and Giebisch's the Kidney (Fifth Edition). Waltham, MA: Academic Press, 2013, pp. 2605–2632.
70.
PeixotoA.J., and BakrisG.L.Chapter 46 – Approach to the patient with hypertensive nephrosclerosis. In: KimmelP.L., RosenbergM.E. eds. Chronic Renal Disease (Second Edition). Waltham, MA: Academic Press, 2020, pp. 737–752.
71.
CanneyM., BirksP., and LevinA.Chapter 6 – Epidemiology of chronic kidney disease—Scope of the problem. In: KimmelP.L., RosenbergM.E. eds. Chronic Renal Disease (Second Edition). Waltham, MA: Academic Press, 2020, pp. 75–89.
72.
BertrandN., and LerouxJ.C.The journey of a drug-carrier in the body: an anatomo-physiological perspective. J Control Release, 161, 152, 2012.
PaoliR., and SamitierJ.Mimicking the kidney: a key role in organ-on-chip development. Micromachines (Basel), 7, 2016.
75.
TariverdianT., ZarintajP., MilanP.B., et al.Nanoengineered Biomaterials for Kidney Regeneration, Nanoengineered Biomaterials for Regenerative Medicine. New York, NY: Elsevier, 2019, pp. 325–344.
76.
AdamsF., QiuT., MarkA., et al.Soft 3d-printed phantom of the human kidney with collecting system. Ann Biomed Eng, 45, 963, 2017.
77.
DankersP.Y., BoomkerJ.M., Huizinga-van der VlagA., et al.Bioengineering of living renal membranes consisting of hierarchical, bioactive supramolecular meshes and human tubular cells. Biomaterials, 32, 723, 2011.
78.
MolletB.B., BogaertsI.L.J., van AlmenG.C., and DankersP.Y.W.A bioartificial environment for kidney epithelial cells based on a supramolecular polymer basement membrane mimic and an organotypical culture system. J Tissue Eng Regen Med, 11, 1820, 2017.
79.
DestefaniA.C., SirtoliG.M., and NogueiraB.V.Advances in the knowledge about kidney decellularization and repopulation. Front Bioeng Biotechnol, 5, 34, 2017.
80.
LegallaisC., KimD., MihailaS.M., et al.Bioengineering organs for blood detoxification. Adv Healthc Mater, 7, e1800430, 2018.
81.
BurtonT.P., and CallananA.A non-woven path: electrospun poly(lactic acid) scaffolds for kidney tissue engineering. Tissue Eng Regen Med, 15, 301, 2018.
82.
DankersP.Y., BoomkerJ.M., Huizinga-van der VlagA., SmedtsF.M., HarmsenM.C., and van LuynM.J.The use of fibrous, supramolecular membranes and human tubular cells for renal epithelial tissue engineering: towards a suitable membrane for a bioartificial kidney. Macromol Biosci, 10, 1345, 2010.
83.
RasouliR., BarhoumA., BechelanyM., and DufresneA.Nanofibers for biomedical and healthcare applications. Macromol Biosci, 19, e1800256, 2019.
84.
LuoW.L., QiuX., ZhangJ., et al.In situ accurate deposition of electrospun medical glue fibers on kidney with auxiliary electrode method for fast hemostasis. Mater Sci Eng C Mater Biol Appl, 101, 380, 2019.
85.
GarretaE., PradoP., TarantinoC., et al.Fine tuning the extracellular environment accelerates the derivation of kidney organoids from human pluripotent stem cells. Nat Mater, 18, 397, 2019.
86.
JansenK., CastilhoM., AartsS., et al.Fabrication of kidney proximal tubule grafts using biofunctionalized electrospun polymer scaffolds. Macromol Biosci, 19, e1800412, 2019.
87.
LuL., SamarasekeraC., and YeowJ.T.W.Creatinine adsorption capacity of electrospun polyacrylonitrile (Pan)-zeolite nanofiber membranes for potential artificial kidney applications. J Appl Polym Sci, 132, n/a, 2015.
88.
WernertV., SchäfO., GhobarkarH., and DenoyelR.Adsorption properties of zeolites for artificial kidney applications. Microporous Mesoporous Mater, 83, 101, 2005.
89.
NamekawaK., Tokoro SchreiberM., AoyagiT., and EbaraM.Fabrication of zeolite–polymer composite nanofibers for removal of uremic toxins from kidney failure patients. Biomater Sci, 2, 2014.
90.
Bergé-LefrancD., VagnerC., CalafR., et al.In vitro elimination of protein bound uremic toxin P-cresol by Mfi-type zeolites. Microporous Mesoporous Mater, 153, 288, 2012.
91.
RoncoC., and ClarkW.R.Haemodialysis membranes. Nat Rev Nephrol, 14, 394, 2018.
92.
LavaudS., CanivetE., WuillaiA., et al.Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane. Nephrol Dial Transplant, 18, 2097, 2003.
93.
ThomasM., ValetteP., MaussetA.L., and DéjardinP.High molecular weight kininogen adsorption on hemodialysis membranes: influence of Ph and relationship with contact phase activation of blood plasma. Influence of pre-treatment with poly(ethyleneimine). Int J Artif Organs, 23, 20, 2000.
94.
PanagiotouA., NalessoF., ZanellaM., et al.Antioxidant dialytic approach with vitamin E-coated membranes. Contrib Nephrol, 171, 101, 2011.
95.
WilmerM.J., NgC.P., LanzH.L., VultoP., Suter-DickL., and MasereeuwR.Kidney-on-a-chip technology for drug-induced nephrotoxicity screening. Trends Biotechnol, 34, 156, 2016.
96.
WangJ.D., DouvilleN.J., TakayamaS., and ElSayedM.Quantitative analysis of molecular absorption into pdms microfluidic channels. Ann Biomed Eng, 40, 1862, 2012.
HomanK.A., GuptaN., KrollK.T., et al.Flow-enhanced vascularization and maturation of kidney organoids in vitro. Nat Methods, 16, 255, 2019.
99.
PhipsonB., ErP.X., CombesA.N., et al.Evaluation of variability in human kidney organoids. Nat Methods, 16, 79, 2019.
100.
SchachnerE.R., HutchinsonJ.R., and FarmerC.Pulmonary anatomy in the Nile crocodile and the evolution of unidirectional airflow in Archosauria. PeerJ, 1, e60, 2013.
LiJ., ChenG., ZhuY., et al.Efficient electrocatalytic Co2 reduction on a three-phase interface. Nat Catal, 1, 592, 2018.
103.
ScottG.R.Elevated performance: the unique physiology of birds that fly at high altitudes. J Exp Biol, 214, 2455, 2011.
104.
Monahan-EarleyR., DvorakA.M., and AirdW.C.Evolutionary origins of the blood vascular system and endothelium. J Thromb Haemost, 11(Suppl 1), 46, 2013.
105.
CardosoW.V., and LuJ.Regulation of early lung morphogenesis: questions, facts and controversies. Development, 133, 1611, 2006.
106.
BartlettR.H.Extracorporeal life support: history and new directions. ASAIO J, 51, 2005.
107.
LiJ., ZhuY., ChenW., et al.Breathing-mimicking electrocatalysis for oxygen evolution and reduction. Joule, 3, 557, 2019.
108.
LemonG., LimM.L., AjalloueianF., and MacchiariniP.The development of the bioartificial lung. Br Med Bull, 110, 35, 2013.
109.
FritscheC.S., SimschO., WeinbergE.J., et al.Pulmonary tissue engineering using dual-compartment polymer scaffolds with integrated vascular tree. Int J Artif Organs, 32, 701, 2009.
110.
WuZ.J., ZhangT., BianchiG., et al.Thirty-day in-vivo performance of a wearable artificial pump-lung for ambulatory respiratory support. Annals Thorac Surg, 93, 274, 2012.
111.
SongJ.J., and OttH.C.Bioartificial lung engineering. Am J Transplant, 12, 283, 2012.
112.
SchildersK.A.A., EenjesE., van RietS., et al.Regeneration of the lung: lung stem cells and the development of lung mimicking devices. Respir Res, 17, 44, 2016.
113.
HuhD., MatthewsB.D., MammotoA., Montoya-ZavalaM., HsinH.Y., and IngberD.E.Reconstituting organ-level lung functions on a chip. Science, 328, 1662, 2010.
114.
LangerR., and VacantiJ.P.Tissue engineering. Science, 260, 920, 1993.
115.
UdelsmanB.V., EatonJ., MuniappanA., MorseC.R., WrightC.D., and MathisenD.J.Repair of large airway defects with bioprosthetic materials. J Thorac Cardiovasc Surg, 152, 1388, 2016.
116.
MacchiariniP., JungebluthP., GoT., et al.Clinical transplantation of a tissue-engineered airway. The Lancet, 372, 2023, 2008.
117.
SjöqvistS., JungebluthP., LimM.L., et al.Editorial expression of concern: experimental orthotopic transplantation of a tissue-engineered oesophagus in rats. Nat Commun, 7, 13310, 2016.
118.
PolkA.A., MaulT.M., McKeelD.T., et al.A Biohybrid artificial lung prototype with active mixing of endothelialized microporous hollow fibers. Biotechnol Bioeng, 106, 490, 2010.
119.
PetrellaF., AcocellaF., BarberisM., et al.Airway fistula closure after stem-cell infusion. N Engl J Med, 372, 96, 2014.
120.
PetrellaF., ToffalorioF., BrizzolaS., et al.Stem cell transplantation effectively occludes bronchopleural fistula in an animal model. Ann Thorac Surg, 97, 480, 2014.
121.
BadylakS.F.Xenogeneic extracellular matrix as a scaffold for tissue reconstruction. Transpl Immunol, 12, 367, 2004.
122.
LutolfM.P., and HubbellJ.A.Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol, 23, 47, 2005.
MillerA.J., DyeB.R., Ferrer-TorresD., et al.Generation of lung organoids from human pluripotent stem cells in vitro. Nat Protoc, 14, 518, 2019.
125.
ChenY.W., HuangS.X., de CarvalhoA., et al.A three-dimensional model of human lung development and disease from pluripotent stem cells. Nat Cell Biol, 19, 542, 2017.
126.
WimmerR.A., LeopoldiA., AichingerM., et al.Human blood vessel organoids as a model of diabetic vasculopathy. Nature, 565, 505, 2019.
127.
GrigoryanB., PaulsenS.J., CorbettD.C., et al.Multivascular networks and functional intravascular topologies within biocompatible hydrogels. Science, 364, 458, 2019.
128.
YapL., WangJ.-W., Moreno-MoralA., et al.In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors. Cell Rep, 26, 3231, 2019.
129.
MuiznieksL.D., and KeeleyF.W.Molecular assembly and mechanical properties of the extracellular matrix: a fibrous protein perspective. Biochim Biophys Acta, 1832, 866, 2013.
130.
ChabiniokR., WangV.Y., HadjicharalambousM., et al.Multiphysics and multiscale modelling, data-model fusion and integration of organ physiology in the clinic: ventricular cardiac mechanics. Interface Focus, 6, 20150083, 2016.
131.
BosmanF.T., and StamenkovicI.Functional structure and composition of the extracellular matrix. J Pathol, 200, 423, 2003.
132.
DuanB.State-of-the-art review of 3d bioprinting for cardiovascular tissue engineering. Ann Biomed Eng, 45, 195, 2016.
133.
Torrent-GuaspF., KocicaM.J., CornoA.F., et al.Towards new understanding of the heart structure and function. Eur J Cardiothorac Surg, 27, 191, 2005.
134.
HintonR.B., and YutzeyK.E.Heart valve structure and function in development and disease. Annu Rev Physiol, 73, 29, 2011.
135.
WilliamsD.F.On the mechanisms of biocompatibility. Biomaterials, 29, 2941, 2008.
136.
ShapiraA., FeinerR., and DvirT.Composite biomaterial scaffolds for cardiac tissue engineering. Int Mater Rev, 61, 1, 2016.
137.
ZimmermannW.H., MelnychenkoI., WasmeierG., et al.Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med, 12, 452, 2006.
138.
LeorJ., Aboulafia-EtzionS., DarA., et al.Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium? Circulation, 102, Iii56, 2000.
139.
YouJ.O., RafatM., YeG.J., and AugusteD.T.Nanoengineering the heart: conductive scaffolds enhance connexin 43 expression. Nano Lett, 11, 3643, 2011.
RenJ., XuQ.F., ChenX.M., et al.Superaligned carbon nanotubes guide oriented cell growth and promote electrophysiological homogeneity for synthetic cardiac tissues. Adv Mater, 29, 2017.
142.
KimD.H., LipkeE.A., KimP., et al.Nanoscale cues regulate the structure and function of macroscopic cardiac tissue constructs. Proc Natl Acad Sci U S A, 107, 565, 2010.
143.
BursacN., LooY., LeongK., and TungL.Novel anisotropic engineered cardiac tissues: studies of electrical propagation. Biochem Biophys Res Commun, 361, 847, 2007.
144.
DunnD.A., HodgeA.J., and LipkeE.A.Biomimetic materials design for cardiac tissue regeneration. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 6, 15, 2014.
145.
TongC., LiC., XieB., et al.Generation of bioartificial hearts using decellularized scaffolds and mixed cells. Biomed Eng Online, 18, 71, 2019.
146.
OttH.C., MatthiesenT.S., GohS.K., et al.Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med, 14, 213, 2008.
147.
ZhangY.S., YueK., AlemanJ., et al.3D bioprinting for tissue and organ fabrication. Ann Biomed Eng, 45, 148, 2017.
148.
VatsA., TolleyN.S., BishopA.E., and PolakJ.M.Embryonic stem cells and tissue engineering: delivering stem cells to the clinic. J R Soc Med, 98, 346, 2005.
149.
LuT.Y., LinB., KimJ., et al.Repopulation of decellularized mouse heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells. Nat Commun, 4, 2307, 2013.
150.
TomaC., PittengerM.F., CahillK.S., ByrneB.J., and KesslerP.D.Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation, 105, 93, 2002.
151.
HongN., YangG.H., LeeJ., and KimG.3D bioprinting and its in vivo applications. J Biomed Mater Res B Appl Biomater, 106, 444, 2018.
152.
NoorN., ShapiraA., EdriR., GalI., WertheimL., and DvirT.3D printing of personalized thick and perfusable cardiac patches and hearts. Adv Sci, 6, 2019. https://doi.org/10.1002/advs.201900344
153.
HoangX.T., CieplakM., BanavarJ., and MaritarA.Predictions of protein secondary structures form conformational biases. Proteins Struct Funct Genet, 48, 558, 2002.
DvirT., TimkoB.P., KohaneD.S., and LangerR.Nanotechnological strategies for engineering complex tissues. Nat Nanotechnol, 6, 13, 2010.
156.
MaX., YuC., WangP., et al.Rapid 3d bioprinting of decellularized extracellular matrix with regionally varied mechanical properties and biomimetic microarchitecture. Biomaterials, 185, 310, 2018.
157.
MillerJ.S., StevensK.R., YangM.T., et al.Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues. Nat Mater, 11, 768, 2012.
158.
KoleskyD.B., HomanK.A., Skylar-ScottM.A., and LewisJ.A.Three-dimensional bioprinting of thick vascularized tissues. Proc Natl Acad Sci U S A, 113, 3179, 2016.
159.
FeinerR., EngelL., FleischerS., et al.Engineered hybrid cardiac patches with multifunctional electronics for online monitoring and regulation of tissue function. Nat Mater, 15, 679, 2016.
160.
DaiX.C., ZhouW., GaoT., LiuJ., and LieberC.M.Three-dimensional mapping and regulation of action potential propagation in nanoelectronics-innervated tissues. Nat Nanotechnol, 11, 776, 2016.
161.
LeeA., HudsonA.R., ShiwarskiD.J., et al.3D bioprinting of collagen to rebuild components of the human heart. Science, 365, 482, 2019.
162.
ChandorkarY., and BasuB.The foreign body response demystified. ACS Biomaterials Science & Engineering, 5, 19, 2018.
163.
Kenneth WardW.A review of the foreign-body response to subcutaneously-implanted devices: the role of macrophages and cytokines in biofouling and fibrosis. J Diabetes Sci Technol, 2, 768, 2008.
164.
BasuB., and GhoshS.Biomaterials for musculoskeletal regeneration. New York, NY: Springer, 2017.
165.
AndersonJ.M., RodriguezA., and ChangD.T.Foreign body reaction to biomaterials. Semin Immunol, 20, 86, 2008.
166.
AndersonJ.M.Biological responses to materials. Ann Rev Mater Res, 31, 81, 2001.
167.
RatnerB.D., HoffmanA.S., SchoenF.J., and LemonsJ.E.Biomaterials science: an introduction to materials in medicine. New York, NY: Elsevier, 2004.
VelnarT., BaileyT., and SmrkoljV.The wound healing process: an overview of the cellular and molecular mechanisms. J Int Med Res, 37, 1528, 2009.
170.
GoliasC., CharalabopoulosA., StagikasD., CharalabopoulosK., and BatistatouA.The kinin system-bradykinin: biological effects and clinical implications. Multiple role of the kinin system-bradykinin. Hippokratia, 11, 124, 2007.
171.
LuttikhuizenD.T., HarmsenM.C., and Van LuynM.J.Cellular and molecular dynamics in the foreign body reaction. Tissue Eng, 12, 1955, 2006.
172.
BasuB.Biomaterials Science and Tissue Engineering: Principles and Methods. Cambridge: Cambridge University Press, 2017.
173.
KyriakidesT.R., FosterM.J., KeeneyG.E., et al.The Cc chemokine ligand, Ccl2/Mcp1, participates in macrophage fusion and foreign body giant cell formation. Am J Pathol, 165, 2157, 2004.
174.
RatnerB.D.Reducing capsular thickness and enhancing angiogenesis around implant drug release systems. J Controlled Release, 78, 211, 2002.
175.
DondossolaE., HolzapfelB.M., AlexanderS., FilippiniS., HutmacherD.W., and FriedlP.Examination of the foreign body response to biomaterials by nonlinear intravital microscopy. Nat Biomed Eng, 1, 0007, 2017.
176.
MinuttiC.M., KnipperJ.A., AllenJ.E., and ZaissD.M.Tissue-specific contribution of macrophages to wound healing. Semin Cell Dev Biol, 61, 3, 2017.
WynnT.A., and VannellaK.M.Macrophages in tissue repair, regeneration, and fibrosis. Immunity, 44, 450, 2016.
179.
ZiatsN.P., MillerK.M., and AndersonJ.M.In vitro and in vivo interactions of cells with biomaterials. Biomaterials, 9, 5, 1988.
180.
YangH.-C., ParkH.C., QuanH., and KimY.Immunomodulation of Biomaterials by Controlling Macrophage Polarization, Biomimetic Medical Materials. New York, NY: Springer, 2018, pp. 197–206.
181.
ZhuX.W., PriceN.M., GilmanR.H., RecarvarrenS., and FriedlandJ.S.Multinucleate giant cells release functionally unopposed matrix metalloproteinase-9 in vitro and in vivo. J Infect Dis, 196, 1076, 2007.
182.
HelmingL., and GordonS.Molecular mediators of macrophage fusion. Trends Cell Biol, 19, 514, 2009.
183.
MooneyJ.E., SummersK.M., GongoraM., et al.Transcriptional switching in macrophages associated with the peritoneal foreign body response. Immunol Cell Biol, 92, 518, 2014.
184.
DamanikF.F., RothuizenT.C., van BlitterswijkC., RotmansJ.I., and MoroniL.Towards an in vitro model mimicking the foreign body response: tailoring the surface properties of biomaterials to modulate extracellular matrix. Sci Rep, 4, 6325, 2014.
185.
MarianiE., LisignoliG., BorzìR.M., and PulsatelliL.Biomaterials: foreign bodies or tuners for the immune response? Int J Mol Sci, 20, 2019.
186.
AbariciaJ.O., ShahA.H., ChaubalM., HotchkissK.M., and Olivares-NavarreteR.Wnt signaling modulates macrophage polarization and is regulated by biomaterial surface properties. Biomaterials, 243, 119920, 2020.
187.
ThevenotP., HuW., and TangL.Surface chemistry influences implant biocompatibility. Curr Top Med Chem, 8, 270, 2008.
188.
ChenS., JonesJ.A., XuY., LowH.Y., AndersonJ.M., and LeongK.W.Characterization of topographical effects on macrophage behavior in a foreign body response model. Biomaterials, 31, 3479, 2010.
189.
NeacsuP., MazareA., CimpeanA., et al.Reduced inflammatory activity of raw 264.7 macrophages on Titania nanotube modified Ti surface. Int J Biochem Cell Biol, 55, 187, 2014.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
